We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$216M
2
CPT icon
Camden Property Trust
CPT
+$180M
3
AMT icon
American Tower
AMT
+$137M
4
PLD icon
Prologis
PLD
+$122M
5
EXR icon
Extra Space Storage
EXR
+$90.4M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$181M
2
AVB icon
AvalonBay Communities
AVB
+$166M
3
HST icon
Host Hotels & Resorts
HST
+$163M
4
REG icon
Regency Centers
REG
+$134M
5
ESS icon
Essex Property Trust
ESS
+$92.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNS
1326
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
58
– –
EIGR
1327
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1K ﹤0.01%
2
– –
KNTE
1328
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$1K ﹤0.01%
127
– –
ICVX
1329
DELISTED
Icosavax, Inc. Common Stock
ICVX
$1K ﹤0.01%
114
– –
AMTI
1330
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$1K ﹤0.01%
132
– –
ICPT
1331
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1K ﹤0.01%
62
– –
EVLO
1332
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$1K ﹤0.01%
8
– –
JNCE
1333
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1K ﹤0.01%
75
– –
PRVB
1334
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1K ﹤0.01%
106
– –
TCDA
1335
DELISTED
Tricida, Inc. Common Stock
TCDA
$1K ﹤0.01%
110
– –
OYST
1336
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$1K ﹤0.01%
76
– –
CLVS
1337
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
406
– –
AERI
1338
DELISTED
Aerie Pharmaceuticals
AERI
$1K ﹤0.01%
102
– –
RDUS
1339
DELISTED
Radius Health, Inc.
RDUS
$1K ﹤0.01%
88
– –
ADVM
1340
DELISTED
Adverum Biotechnologies
ADVM
$0 ﹤0.01%
18
– –
AKBA icon
1341
Akebia Therapeutics
AKBA
$335M
$0 ﹤0.01%
316
– –
ALGS icon
1342
Aligos Therapeutics
ALGS
$26.1M
$0 ﹤0.01%
5
– –
ANNX icon
1343
Annexon
ANNX
$791M
$0 ﹤0.01%
131
– –
APLT
1344
DELISTED
Applied Therapeutics
APLT
$0 ﹤0.01%
42
– –
ARRY icon
1345
Array Technologies
ARRY
$749M
– –
-46,900
Closed -$735K
AUTL
1346
Autolus Therapeutics
AUTL
$378M
$0 ﹤0.01%
74
– –
BDTX icon
1347
Black Diamond Therapeutics
BDTX
$95.7M
$0 ﹤0.01%
106
– –
BDX icon
1348
PUT
Becton Dickinson
BDX
$46.5B
– –
-103
Closed -$161K
BILI icon
1349
Bilibili
BILI
$7.77B
– –
-21,350
Closed -$991K
CABA icon
1350
Cabaletta Bio
CABA
$435M
$0 ﹤0.01%
45
– –
52 53
54
55 56

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.